Active, Not Recruiting
Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma
NCT06898970
- Conditions
- Angiosarcoma, Angiosarcoma, Adult, Hemangiosarcoma, +5 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States